Addex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy



Addex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy



READ SOURCE

READ  Ellington Residential Mortgage REIT declares $0.28 dividend

LEAVE A REPLY

Please enter your comment!
Please enter your name here